ASCRS Focus on Cataract Surgery | ASCRS
ASCRS Clinical Education

ASCRS Focus on Cataract Surgery

Light Adjustable Lens

June 2022 update

As technology continues to evolve, today's refractive cataract surgeon must stay up to date on new IOL technologies as they enter the market. One such advancement is the light adjustable lens, which began its commercial launch in the United States in September 2019 and has continued to expand in usage due to its refractive benefits. This lens can be adjusted postoperatively in order to optimize refractive outcomes for difficult cases.

In this updated ASCRS Focus on Cataract Surgery, explore a curated library of the latest educational resources on the light adjustable IOL.

Early experience with the LAL - how to incorporate the technology

Presented by Nicole Fram, MD
In this presentation from the 2022 Winter Symposium, Nicole Fram, MD, covers basics on the light-adjustable lens and why the light-adjustable lens may be a benefit to your practice.

The future is here with the light adjustable lens, which
allows for postoperative power adjustments as much as +/- 2D sphere and +/- 2D
Kevin M. Miller, MD

EyeWorld Article

Using the Light Adjustable Lens in practice

by Ellen Stodola, Editorial Co-Director
September 2021
The Light Adjustable Lens (LAL, RxSight) offers the unique opportunity to lock in the preferred vision after surgery. With recent updates, the technology can be an attractive option for a variety of refractive cataract patients. Several surgeons discussed how they use this IOL in their practice....

Read more on >>

EyeWorld Article

What to know about the Light Adjustable Lens

by Ellen Stodola, Editorial Co-Director
September 2018
Though FDA approved, the Light Adjustable Lens (LAL, RxSight, Aliso Viejo, California) is not yet currently available in the U.S. Robert Maloney, MD, Los Angeles, John Doane, MD, Leawood, Kansas, David F. Chang, MD, Los Altos, California, and Kevin Waltz, MD, Indianapolis, discussed their experience with the lens in clinical trial, how it works, and for what corrections it has approval....

Read more on >>

JCRS Article

Long-term follow-up and clinical evaluation of the light-adjustable intraocular lens implanted after cataract removal: 7-year results

Journal of Cataract & Refractive Surgery: January 2020 - Volume 46 - Issue 1

Authors: Schojai, Merita MD; Schultz, Tim MD; Schulze, Katrin MD; Hengerer, Fritz H. MD, PhD; Dick, H. Burkhard MD, PhD

The purpose of this study is to determine the long-term safety and effectiveness of a light-adjustable intraocular lens (LAL) over a period that is longer than reported in the literature at the time of the study.

Featured Scientific Paper Presentation

Visual Outcomes of Patients Bilaterally Implanted with the Light Adjustable Lens

Captured at the 2022 ASCRS Annual Meeting

Session: SPS-208 Cataract IOLs- Monofocal/Extended Depth of Focus
Presenting Author: Kerry D. Solomon, MD
Authors: Richard J Potvin, OD, Helga P. Sandoval, MD, MSc

The purpose of this paper is to evaluate visual outcomes after implantation and light treatment of a light adjustable lens (LAL) in patients after routine cataract surgery.


View Paper Presentation

We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.